Deciphering a hydrogen sulfide-related signature to supervise prognosis and therapeutic response in colon adenocarcinoma

被引:0
|
作者
Chen, Jinbiao [1 ]
Zhang, Yingchun [1 ]
机构
[1] Zhejiang Univ, Hangzhou Xixi Hosp, Med Coll, Dept Oncol, Hangzhou 310023, Zhejiang, Peoples R China
关键词
colon adenocarcinoma; hydrogen sulfide; immunotherapy; nomogram; prognosis; CLASS DISCOVERY; CANCER; RESISTANCE;
D O I
10.1097/MD.0000000000040031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hydrogen sulfide (H2S) is a critical molecule that participates in various molecular, physiological, and pathophysiological processes in biological systems. Emerging evidence has revealed that H2S is implicated in the progression of colon cancer and immune escape. Against this backdrop, the present study aimed to construct a prognostic risk feature for colon adenocarcinoma (COAD) by leveraging hydrogen sulfide-related genes (HSRG). Transcriptomic data and corresponding clinical-pathological information of colon cancer were obtained from The Cancer Genome Atlas and gene expression omnibus databases. Univariate Cox regression analysis was employed to assess the prognostic relevance of HSRG. Consensus clustering was utilized to perform molecular subtyping of COAD, followed by comparison of immune cell infiltration, drug sensitivity, and immune therapy response between subtypes. Differential expression gene and gene set enrichment analyses were conducted between subtypes. Univariate, lasso, and multivariate Cox regression analyses were applied to construct a prognostic model derived from HSRG. A nomogram model for predicting COAD prognosis was constructed and evaluated. In this study, we identified 12 HSRGs that were associated with COAD prognosis. Consensus clustering analysis revealed 3 COAD molecular subtypes that exhibited significant differences in terms of prognosis, tumor immune cell infiltration, drug sensitivity, and immune therapy response. Gene set enrichment analysis demonstrated that immunoregulatory processes were significantly suppressed in the poor-prognosis subtype while Wnt-related pathways and processes were significantly upregulated. Based on the differentially expressed genes between subtypes, we constructed a risk model comprising 11 genes that effectively distinguished high-risk patients from low-risk patients with significant associations with patient survival outcomes, drug treatment, pathological staging, and T staging. The HSRG-derived risk feature was an independent prognostic factor for COAD in drug treatment and pathological staging and could be integrated into a nomogram for prognosis prediction. Calibration curve, receiver operating characteristic curve, and decision curve analysis demonstrated excellent performance of the nomogram in evaluating COAD prognosis. Our study systematically assessed the prognostic significance of HSRG in COAD, identified HSRG-based molecular subtypes and risk features, and highlighted their potential utility in predicting prognosis and treatment response.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] A Novel TGF-β-Related Signature for Predicting Prognosis, Tumor Microenvironment, and Therapeutic Response in Colorectal Cancer
    Tao, Baorui
    Yi, Chenhe
    Ma, Yue
    Li, Yitong
    Zhang, Bo
    Geng, Yan
    Chen, Zhenmei
    Ma, Xiaochen
    Chen, Jinhong
    BIOCHEMICAL GENETICS, 2023, 62 (4) : 2999 - 3029
  • [32] Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma
    Liu, Xia
    Fang, Xisheng
    Lu, Lin
    Liu, Guolong
    FRONTIERS IN GENETICS, 2022, 13
  • [33] Determination of a DNA repair-related gene signature with potential implications for prognosis and therapeutic response in pancreatic adenocarcinoma
    Lai, Jinzhi
    Chen, Weijie
    Zhao, Aiyue
    Huang, Jingshan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
    Li, Dongming
    Qu, Guangzhen
    Ling, Shen
    Sun, Yuanlin
    Cui, Yingnan
    Yang, Yingchi
    Cao, Xueyuan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [35] A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma
    He, Xiaolan
    Xu, Zhengyang
    Ren, Ruiping
    Wan, Peng
    Zhang, Yu
    Wang, Liangliang
    Han, Ying
    HELIYON, 2024, 10 (01)
  • [36] A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients
    Liu, Le
    Liang, Liping
    Mai, Genghui
    Chen, Ye
    FASEB BIOADVANCES, 2022, 4 (09) : 585 - 601
  • [37] A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer
    Xiao, Shilang
    Liu, Xiaoming
    Yuan, Lingzhi
    Wang, Fen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [38] Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
    Sun, Zihao
    Chen, Xiujing
    Huang, Xiaoning
    Wu, Yanfen
    Shao, Lijuan
    Zhou, Suna
    Zheng, Zhu
    Lin, Yiguang
    Chen, Size
    LIFE-BASEL, 2023, 13 (07):
  • [39] An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma
    Zitao Liu
    Liang Sun
    Xingyu Peng
    Sicheng Liu
    Zhengming Zhu
    Chao Huang
    Apoptosis, 2023, 28 : 1564 - 1583
  • [40] Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
    Chang, Wuguang
    Li, Hongmu
    Cheng, Yixin
    He, Huanhuan
    Ou, Wei
    Wang, Si-Yu
    FRONTIERS IN IMMUNOLOGY, 2023, 14